Isabelle Cleynen
About
In The Last Decade
Isabelle Cleynen
94 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 110
- Genetics 1.7k
- Epidemiology 1.1k
- Molecular Biology 1.0k
- Immunology 958
- Surgery 623
Countries citing papers authored by Isabelle Cleynen
This map shows the geographic impact of Isabelle Cleynen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Cleynen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Cleynen more than expected).
Fields of papers citing papers by Isabelle Cleynen
This network shows the impact of papers produced by Isabelle Cleynen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Cleynen. The network helps show where Isabelle Cleynen may publish in the future.
Co-authorship network of co-authors of Isabelle Cleynen
This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Cleynen. A scholar is included among the top collaborators of Isabelle Cleynen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Cleynen. Isabelle Cleynen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 20 | |
| 4 | 9 | |
| 5 | 30 | |
| 6 | 5 | |
| 7 | 8 | |
| 8 | 119 | |
| 9 | A variable number of tandem repeat polymorphism in the promotor region of the neonatal Fc receptor affects anti-tumour necrosis factor serum levels in inflammatory bowel disease | 2 |
| 10 | 124 | |
| 11 | 48 | |
| 12 | Disease burden outweighs the impact of drug concentrations and antibodies to infliximab in primary non-response to infliximab in Crohn's disease patients | 2 |
| 13 | Anti-TNF-induced skin manifestations in IBD patients: role for increased drug exposure? | 1 |
| 14 | 47 | |
| 15 | 28 | |
| 16 | 22 | |
| 17 | 22 | |
| 18 | Anti-TNF induced skin manifestations in IBD patients: characterization and search for predisposing factors | 5 |
| 19 | Long term evolution and impact of immunomodulator cotreatment and withdrawal on infliximab on trough levels in 223 patients with Crohn's disease | 2 |
| 20 | 150 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.